MISSISSAUGA, ON, May 4, 2023
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or
"the Company") today announced that it will release its
financial results for the first quarter of 2023 on Thursday, May 11, 2023. The Company will also
host a conference call on Friday, May 12,
2023 at 8:30am ET to discuss
the results and corporate developments.
CONFERENCE CALL DETAILS
DATE:
Friday, May 12, 2023
TIME:
8:30 a.m. EDT
DIAL-IN
NUMBER:
(416) 764-8650 or (888) 664-6383
CONFERENCE
ID:
40452017
REPLAY
DIAL-IN:
(888) 390-0541 (playback 452017#)
Expires May 19, 2022
WEBCAST:
https://app.webinar.net/wOPDyeLaKb0
About Cipher Pharmaceuticals Inc.
Cipher
Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company
with a robust and diversified portfolio of commercial and early to
late-stage products. Cipher acquires products that fulfill unmet
medical needs, manages the required clinical development and
regulatory approval process, and currently markets those products
either directly in Canada or
indirectly through partners in Canada, the U.S., and South America. For more information, visit
www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.